People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vigeo Therapeutics, Inc. | — | Biotechnology | Series A | $17.6M | $195.3M | 2021 |
Stephanie E. O'Brien at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephanie E. O'Brien on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter B. Finn | 1 | 11 |
| Jason Dinges | 1 | 8 |
| Stephanie O'Brien | 1 | 7 |
| Jing Watnick | 1 | 1 |
| Westerly E. Nolin, Ph.D. | 1 | 1 |
| James E. Mahoney | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.